More jobs to foreign countries ... Pharmaceutical Research next?
Another industry gearing up to send American jobs to a foreign
country, this time the Pharmaceutical Industry. Of course we will be
told how this is
. Both major parties, the Republicans and
Democrats and especially the current Bush Administration continue to
treat offshoring - the sending of American jobs to foreign countries
as a boost to our country's economy (
Bush policy - over-invested in high-cost geographies like the U.S.).
Over and over we are told how this creates more jobs than are
lost. But it is a stretch to find an empty factory or research
lab that employs many people. But they continue to tell us that
sending jobs is
. As the number of empty factories, call centers,
banking centers, human resource centers, high tech development
centers and soon pharmaceutical research centers become empty - one
fact can not be disputed. The Americans who used to work there - do
not work there any longer. But we are told that this is
Many of our elected politicians provide eloquent statements about
this loss of jobs and expertise is
for us - but they never count the real costs and effects on
our citizens, economy and society.
Every lost job has a real impact on the family that was supported
by that job. Lost salaries do not pay bills. Unemployment benefits
are paid either by tax payers or contribute to the cost of goods and
service in the form of unemployment insurance paid by employers.
Long term unemployment or lowered salary on replacement jobs have a
direct effect on the affected family. Costs to society contribute to
the growing expense side of local, State and federal budgets.
For every service or product that moves offshore it weakens our
country's economy. The services or products are now imports and
contribute to the continuing deterioration of our country's
international trade position which is running massive deficits (See:
Bush Economic Polices - Once again - bragging about trade deficit
).. These deficits can not continue
These are real, very real on the personal level, impacts of the
current policy of encouraging outsourcing. We especially hold the
Bush Administration responsible. In his re-election campaign last
year both the Elect Bush Campaign and Republican National Committee
used call centers in India to perform millions of telephone calls
India claims big election victory and laughs
You are presented explanations about how this is "Free Trade."
That Free Trade is good for both sides. However this is actually
"Expensive Trade" and you are providing in effect a citizen supplied
subsidy for the multi-national corporations that are utilizing
outsourcing. Free Trade or Expensive Trade are just terms to
describe the effects of the current Administration and major party
supported Trade Policy. Look at who benefits - multinational
corporations and those they support. Since they benefit they use the
much touted term "Free Trade." Look at who pays the price - our
citizens and country. You should be using the term "Expensive
Our government at all levels has the duty to represent both
citizens and special interests, not just special interests. Our
government should be worked for "Fair Trade." A trade policy that is
balanced, where overall trade between between our country and a
foreign country is balanced (See:
A Southern Party of Georgia Position on solving our country�s Trade
). Only when trade is balanced can both trading
In our current trade policy our country and its citizens lose!
Until you - the citizens demand a change, you are stuck with
"Expensive Trade." It is up to you to decide how long you will let
multinational corporations and foreign countries to continue to reap
the benefits while you pay the price - both directly and indirectly.
The next time you hear some politician talking about how the
current "Free Trade" is
for us - let them know that you will not vote for them again
until they support Fair Trade! And do it! Until then nothing will
The following article gives fair warning of what is coming for
the Pharmaceutical Industry.
|`Pharma sector to be worth $48 bn by
|Our Corporate Bureau / New Delhi May
|The Indian pharmaceutical sector can be worth $48
billion by the year 2007 from the present $6 billion,
according to a study by the Confederation of Indian
|The CII study predicts that India could become a
global leader by exporting domestically produced generic
products and presenting itself as an offshoring location
for clinical and pre-clinical research amongst other
|The study projects that it will be imperative for
Indian companies to leverage emerging opportunities and
meet key challenges to achieve this target.
|However, it depends on the ability to withstand shocks
and consistently deliver profitable growth. It will also
be important to focus on operational excellence, the study
observes. If India were to evolve on the global landscape,
it will largely be through consolidating and creating
large global generic players.
|This argument gains ground if one were to look at the
international scenario where top 10 generic players
already constitute 27 per cent of the global market.
|The study lays special stress on R&D especially for
chronic diseases, lifestyle drugs and life threatening
diseases. In India, the spending on life threatening
ailments especially is abysmally low, and that has to
|Greater incentives in this aspect need to be provided
through higher EXIM Bank allocations, public-private
partnerships and an increased budgetary allocation for
research,the study suggests while special zones,
registration of global sourcing units for extended tax
holidays and facility of soft loans will give a leg up to
contract manufacturing facilities.
|For clinical trials, there is a need to improve the
regulatory approval process and increase public awareness
|The study has also focused on the need for creating
ethics committees for private hospitals and thereafter
|The global industry is currently worth $550 billion,
while the Indian pharmaceutical industry is pegged at $6
billion , growing at 10 per cent per annum.
|India�s share in the global generics market is likely
to be significant on patent expiry and is expected to grow
from the current 4 per cent to around 33 per cent.
If you believe in Our Founding Principles the following
article might be of interest:
ask, "Why a Southern Party �?"